FDA Updates

Dr. Reddy’s Laboratories has launched moxifloxacin HCl tablets, 400 mg, a therapeutic equivalent generic version of Avelox on March 4, following FDA approval.

FDA approved droxidopa (Northera, Chelsea Therapeutics) capsules for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating condition that is associated with Parkinson's disease, multiple-system atrophy, and pure autonomic failure.

New Products

New Rx, generics, and OTC products for pharmacists

New Products

New Rx, generics, and OTC for pharmacists

New Products

New Rx, generics, OTC, and devices

With its interpretation, HHS effectively eliminated approximately $1.50 per reminder in payments made to pharmacies by drug manufacturers.

New products

New Rx, indications, generics, OTC, and devices.

August is a great time for many families to enjoy the outdoors before school starts. Anyone preparing for a camping trip, a hike, a boating adventure, biking, or just swimming should prepare a first aid kit for any unexpected mishaps. Some new items to add to the kit are described below.

FDA approved levomilnacipran extended-release capsules (Fetzima) for the treatment of major depressive disorder (MDD) in adults, according to the manufacturers, Forest Laboratories and Pierre Fabre Laboratories.

New Products

New Rx, indications, generics, and OTC for pharmacists

Aceto Corporation, Port Washington, N.Y., announced June 11 that its generics subsidiary, Rising Pharmaceuticals Inc., Paramus, N.J., will launch the 50-mg strength of riluzole tablets.

Sandoz has become the first company to gain the FDA approval to produce a generic version of Atacand (candesartan cilexetil).